✦ LIBER ✦

Histiocytic lymphoma of the ileocecal region after chemotherapy for multiple myeloma

✍ Scribed by Silloo B. Kapadia

Publisher: John Wiley and Sons
Year: 1979
Tongue: English
Weight: 530 KB
Volume: 43
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197902)43:2<435::aid-cncr2820430205>3.0.co;2-g

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acute exacerbation of hepatitis due to r

Acute exacerbation of hepatitis due to reactivation of hepatitis B virus with mutations in the core region after chemotherapy for malignant lymphoma

✍ Tsutomu Sato; Junji Kato; Johji Kawanishi; Katsuhisa Kogawa; Masami Ohya; Sumio 📂 Article 📅 1997 🏛 Springer Japan 🌐 English ⚖ 693 KB

Myeloma cell contamination of peripheral

Myeloma cell contamination of peripheral blood stem-cell grafts can predict the outcome in multiple myeloma patients after high-dose chemotherapy and autologous stem-cell transplantation

✍ Wichard Vogel; Hans-Georg Kopp; Lothar Kanz; Hermann Einsele 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 245 KB

Novel evidence of a role for chromosome

Novel evidence of a role for chromosome 1 pericentric heterochromatin in the pathogenesis of B-cell lymphoma and multiple myeloma

✍ Patricia Le Baccon; Dominique Leroux; Christina Dascalescu; Samuel Duley; Daniel 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 322 KB

## Abstract 1q rearrangement is a remarkably frequent secondary chromosomal change in both non‐Hodgkin's lymphoma (NHL) and multiple myeloma (MM), where it is associated with tumor progression. To gain insight into 1q rearrangement‐associated disease mechanisms, we used fluorescence in situ hybridi

The importance of a sub-region on chromo

The importance of a sub-region on chromosome 19q13.3 for prognosis of multiple myeloma patients after high-dose treatment and stem cell support: a linkage disequilibrium mapping inRAIandCD3EAP

✍ Annette J. Vangsted; Tobias Wirenfeldt Klausen; Peter Gimsing; Niels Abildgaard; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 548 KB

VP-16, ifosfamide, and methotrexate comb

VP-16, ifosfamide, and methotrexate combination chemotherapy for aggressive non-Hodgkin's lymphomas after failure of the LNH 84 regimen

✍ R. Herbrecht; J. J. Garcia; J. P. Bergerat; P. Dufour; B. Duclos; F. Oberling 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 146 KB

Single nucleotide polymorphisms in the p

Single nucleotide polymorphisms in the promoter region of theIL1Bgene influence outcome in multiple myeloma patients treated with high-dose chemotherapy independently of relapse treatment with thalidomide and bortezomib

✍ Annette J. Vangsted; Tobias W. Klausen; Niels Abildgaard; Niels F. Andersen; Pet 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 509 KB